AChE-IN-3

CAS No. 2713548-95-7

AChE-IN-3( —— )

Catalog No. M35201 CAS No. 2713548-95-7

AChE-IN-3 had inhibitory effect on AChE and stronger inhibitory effect on NO, with EC50 of 0.57 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 39 In Stock
10MG 59 In Stock
25MG 98 In Stock
50MG 145 In Stock
100MG 210 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AChE-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    AChE-IN-3 had inhibitory effect on AChE and stronger inhibitory effect on NO, with EC50 of 0.57 μM.
  • Description
    AChE-IN-3 shows moderate inhibitory activity against AChE and strong NO inhibitory activity with an EC50 of 0.57 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    AChE
  • Recptor
    AChE | NO Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2713548-95-7
  • Formula Weight
    427.45
  • Molecular Formula
    C25H21N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (233.95 mM; Ultrasonic )
  • SMILES
    CC1(C)Oc2ccc(cc2O1)C(\Cn1ccnc1)=N/OC(=O)c1ccc2ccccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ren B, et al. Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships. Eur J Med Chem. 2022 Jan 15;228:114031.?
molnova catalog
related products
  • 1-[10-(pyridin-1-ium...

    1-[10-(pyridin-1-ium-1-yl)decyl]pyridin-1-ium dibromide is the inhibitor of human erythrocyte AChE.

  • Demecarium bromide

    Demecarium bromide is a potent cholinesterase inhibitorand is treatment glaucoma agent.

  • Desoxypeganine

    Desoxypeganine is an inhibitor of cholinesterase. It acting preferentially on butyrylcholinesterase, and as a selective inhibitor of monoamine oxidase A but not monoamine oxidase B.